EUVIMEDOpdag EUVIMED
Crossref

From the Editor-in-Chief: Stem-to-Stern, Continuous Process for Biologics?

Keith L. Carson

BioProcessing Journal · 2026-07-27 · 4

DOI: 10.12665/j123.carson ↗

At a glance

Journal article in BioProcessing Journal, published online on 2026-07-27. Written by Keith L. Carson.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Call me jaded. One of the latest fads in the production of biologics is “continuous processing.” So let’s concede that the upstream realm can lend itself to continuous processing, but the really hard stuff was always on the downstream side. Here we’ve had to deal with product clarification and purification, which typically involve crossflow (tangential) filtration and chromatography run in a batch mode, with regeneration steps in between whatever was considered a batch...

Cite

APA

Carson, K. L. (2026). From the Editor-in-Chief: Stem-to-Stern, Continuous Process for Biologics?. BioProcessing Journal, 4. https://doi.org/10.12665/j123.carson

Vancouver

Carson KL. From the Editor-in-Chief: Stem-to-Stern, Continuous Process for Biologics?. BioProcessing Journal. 2026:4. doi:10.12665/j123.carson

BibTeX
@article{Carson2026,
  author = {Carson, Keith L.},
  title = {From the Editor-in-Chief: Stem-to-Stern, Continuous Process for Biologics?},
  journal = {BioProcessing Journal},
  year = {2026},
  pages = {4},
  doi = {10.12665/j123.carson}
}
Start for free →